Title: Revolutionizing Blood Tests: Personalized Blood Count Reference Ranges
Article:
In a groundbreaking study published in Nature, researchers have discovered that using personalized reference ranges for routine blood tests, such as the Complete Blood Count (CBC), could significantly enhance patient health evaluations and enable earlier disease diagnosis, even when patients appear healthy. The study, involving over 12,000 adults whose CBC test results were analyzed over two decades, suggests that traditional, one-size-fits-all reference ranges may not be optimal.
Blood test parameters vary due to factors like genetics, medical history, and age. The study indicates that each individual has a stable value around which their blood test parameters fluctuate. By defining personalized reference ranges for each patient, health professionals can distinguish a patient’s values from those of 98% of healthy adults, providing a more accurate picture of the patient’s health status.
Comparing a patient’s subsequent CBC results with their own historical results offers a clearer understanding of their health than comparing them to external, standardized norms. This personalized approach, the study reveals, is sufficient and specific enough to ensure precise medical interventions in adults.
Intriguingly, personalized reference ranges were linked to significant variations in clinical risks. The absolute risk for common diseases such as heart disease, stroke, diabetes, kidney disease, and osteoporosis differed by over 2% across the population, while the 10-year all-cause mortality risk varied by over 5%.
By defining personalized reference ranges, healthcare professionals can personalize diagnostic interpretations, improving the sensitivity and specificity of tests for common conditions like diabetes, kidney disease, thyroid dysfunction, iron deficiency, and blood cancers.
Consequently, common diseases could be detected early, enabling timely interventions and improved patient outcomes. Moreover, combining personalized CBC reference ranges with other screening markers may enhance the accuracy of early disease detection for various conditions.
Sources:
- Nature: https://www.nature.com/articles/s41586-024-08264-5
- Harvard Medical School